Head-to-head · WeighScore
CLYR Health vs Found
The verdict
Found takes it — 83.5/100 to 62.2/100.
Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | CLYR Health | Found |
|---|---|---|
| WeighScore | 62.2/100 | 83.5/100 |
| Grade | C | B |
| Site position | #310 | #9 |
| Semaglutide | $169 per 28-day vial (starting dose, compounded; higher doses $199–229) | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay |
| Tirzepatide | $149 first month (starting dose, compounded; continuing doses $249–329/month) | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #310 · C
Strengths
- Dose-specific prices and one- or two-month purchase totals are published before intake
- Product pages include consultation, medication, syringes, and shipping in the price
- Terms name MD Integrations and The Pharmacy Hub as partners
- Brand-name and oral options are also listed in the weight-loss catalog
Where it loses points
- Prices rise by dose; the tirzepatide starter offer is not a continuing flat rate
- Product pages promise one-time billing but general terms still describe subscriptions and stricter refund rules
- The semaglutide page contains conflicting cold-pack and room-temperature shipping descriptions
- State eligibility depends on treatment and is checked during intake
Site position #9 · B
Strengths
- Widest medication list in this ranking — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
- Flat pricing as the dose increases, so a titration does not raise the monthly cost
- Bills insurance for the clinical visits — the site states most members pay under $30 per visit
- Runs a dedicated GLP-1 microdose program for people who want a lower starting dose
Where it loses points
- The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
- Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
- The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
- Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
Featured provider
Found
Found scores 83.5/100 (B). The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.